Get informed when a big investor buys or sells
+ FollowOvervalued by 80.2% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $860.76 Million |
|---|---|
| Enterprise Value | $-3,766,548,088.00 |
| Earnings per Share | $-29.8 |
| Beta | 0.53 |
| Outstanding Shares | 128,567,724 |
| P/E Ratio | -47.42 |
|---|---|
| PEG | 70.48 |
| Price to Sales | 0.04 |
| Price to Book Ratio | 0.02 |
| Enterprise Value to Revenue | 6.46 |
| Enterprise Value to EBIT | -35.1 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | 0.12 |
| Debt to Equity | 0.32 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
PeptiDream Inc. functions as a biopharmaceutical enterprise, concentrating on the identification and progression of therapeutic compounds such as constrained peptides, small molecules, and peptide-drug conjugates. The company's unique pr...